States settle with drug company: $68.5 million judgment

Thirty-eight state attorneys general have settled with the maker of an anti-psychotic drug, resolving charges of misleading marketing for the medication.

The Attorneys General charged violations in each state, alleging the...

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@mlex.com

FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch